Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

Charles V. Pollack, Paul Reilly, Joanne van Ryn, +17

New England Journal of Medicine

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

Hans‐Christoph Diener, Ralph L. Sacco, J. Donald Easton, +21

New England Journal of Medicine

Use of Intravascular Ultrasound to Compare Effects of Different Strategies of Lipid-Lowering Therapy on Plaque Volume and Composition in Patients With Coronary Artery Disease

M Schartl, Wolfgang Bocksch, Dietmar Koschyk, +5

Circulation

AT ₁ Receptor Agonistic Antibodies From Preeclamptic Patients Stimulate NADPH Oxidase

Ralf Dechend, Christiane Viedt, Dominik N. Müller, +13

Circulation

Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial

Stephan Glund, Joachim Stangier, Michael Schmohl, +8

The Lancet

ThrombosisVenous ThrombosisCardiovascular DiseaseAnticoagulant EffectHealthy Male Volunteers +6

AT ₁ Receptor Agonistic Antibodies From Preeclamptic Patients Cause Vascular Cells to Express Tissue Factor

Ralf Dechend, Volker Homuth, Gerd Wallukat, +8

Circulation

Differential Activation of Mitogen-Activated Protein Kinases in Smooth Muscle Cells by Angiotensin II

Christiane Viedt, Ubaldo Soto, Heidemarie I. Krieger‐Brauer, +4

Arteriosclerosis Thrombosis and Vascular Biology

P38 Map KinaseInhibited P38 MapkP38 MapkCellular PhysiologyOxidative Stress +20

MCP-1 Induces Inflammatory Activation of Human Tubular Epithelial Cells

Christiane Viedt, R Dechend, Jianwei Fei, +3

Journal of the American Society of Nephrology

ImmunologyRenal InflammationImmunologic MechanismImmunotherapyCellular Physiology +15

Monocyte Chemoattractant Protein-1 Induces Proliferation and Interleukin-6 Production in Human Smooth Muscle Cells by Differential Activation of Nuclear Factor-κB and Activator Protein-1

Christiane Viedt, Judith Vogel, Thomas Athanasiou, +4

Arteriosclerosis Thrombosis and Vascular Biology

Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer

Samuel Z. Goldhaber, Clive Kearon, Ajay K. Kakkar, +6

Thrombosis and Haemostasis